Substitution of n-heptane for ethyl ether in USP assay for chlorpromazine hydrochloride in tablets, injections, and sirups.
Peroxide levels above 0.0001% in the ethyl ether used in the USP XIX assay for chlorpromazine hydrochloride in tablets, sirups, and injections produce a distorted spectrophotometric curve in the 350--220 nm region. The use of peroxide-free ethyl ether or n-heptane avoids this problem. Recoveries of 91-100% are obtained with either of these reagents.